Cargando…
Cannabinoids in Medical Practice
Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating c...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576598/ https://www.ncbi.nlm.nih.gov/pubmed/28861478 http://dx.doi.org/10.1089/can.2015.0010 |
_version_ | 1783260211931250688 |
---|---|
author | Strouse, Thomas B. |
author_facet | Strouse, Thomas B. |
author_sort | Strouse, Thomas B. |
collection | PubMed |
description | Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating chemotherapy-related nausea and vomiting, poor appetite in advanced HIV, some pain states, and multiple sclerosis-associated spasticity. Recreational cannabinoid use has many known potential serious harms. Physicians should be knowledgeable about cannabinoids and should inquire with their patients about cannabinoid use. Practical suggestions for clinical approaches are included. |
format | Online Article Text |
id | pubmed-5576598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55765982017-08-31 Cannabinoids in Medical Practice Strouse, Thomas B. Cannabis Cannabinoid Res Perspective Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating chemotherapy-related nausea and vomiting, poor appetite in advanced HIV, some pain states, and multiple sclerosis-associated spasticity. Recreational cannabinoid use has many known potential serious harms. Physicians should be knowledgeable about cannabinoids and should inquire with their patients about cannabinoid use. Practical suggestions for clinical approaches are included. Mary Ann Liebert, Inc. 2016-01-01 /pmc/articles/PMC5576598/ /pubmed/28861478 http://dx.doi.org/10.1089/can.2015.0010 Text en © Thomas B. Strouse 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Perspective Strouse, Thomas B. Cannabinoids in Medical Practice |
title | Cannabinoids in Medical Practice |
title_full | Cannabinoids in Medical Practice |
title_fullStr | Cannabinoids in Medical Practice |
title_full_unstemmed | Cannabinoids in Medical Practice |
title_short | Cannabinoids in Medical Practice |
title_sort | cannabinoids in medical practice |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576598/ https://www.ncbi.nlm.nih.gov/pubmed/28861478 http://dx.doi.org/10.1089/can.2015.0010 |
work_keys_str_mv | AT strousethomasb cannabinoidsinmedicalpractice |